Oculis Holding AG OCS
9.27
(0.14)
(1.49%)
as of 25 Sep
- Market cap
- $579.5M
- P/E
- 0.0×
Follow OCS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
577.09 | 1,121.34 | 720.95 | 977.18 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(33.41) | (80.03) | (57.88) | (50.81) | |
P/B ratio |
3.06 | 6.24 | 4.41 | 5.64 | |
Price to Tangible BV |
3.26 | 6.69 | 4.73 | 6.28 | |
EV/Sales |
382.70 | 920.42 | 545.04 | 787.71 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.94) | (16.38) | (9.86) | (10.16) | |
EV/FCF |
(6.82) | (16.04) | (9.65) | (9.66) | |
Quick Ratio |
8.18 | 5.06 | 5.80 | 4.30 | |
Current Ratio |
8.35 | 5.18 | 5.96 | 4.47 | |
Net Debt/EBITDA |
9.68 | 10.21 | 9.94 | 7.11 | |
Debt/Assets |
0.72% | 0.75% | 0.77% | 1.22% | |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.02 | |
Asset Turnover |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF/Net income |
2.02 | 0.53 | 0.59 | 0.86 | |
Capex/Depreciation |
(0.08) | (0.05) | 0.07 | (1.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4,930.55% | 6,720.70% | 3,285.34% | 5,810.01% | |
Selling, General and Administrative Expense of Revenue |
2,772.90% | 3,775.67% | 1,877.26% | 2,643.05% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.06 | 0.08 | |
Share Based Compensation of Revenue |
2,129.37% | 2,392.88% | 922.56% | 1,965.61% | |
Graham Net Nets |
0.30 | 0.15 | 0.21 | 0.15 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(12.55%) | (8.01%) | (11.37%) | (14.33%) | |
Free Cash Flow Yield |
(9.73%) | (5.12%) | (7.83%) | (8.35%) | |
Revenue per Share |
0.01 | 0.00 | 0.01 | 0.01 | |
Operating CF per Share |
(0.42) | (0.33) | (0.34) | (0.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.42) | (0.33) | (0.34) | (0.35) | |
Cash per Share |
4.72 | 4.81 | 4.92 | 3.46 | |
Shareholders Equity per Share |
4.53 | 4.26 | 4.53 | 3.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.53 | 4.26 | 4.53 | 3.12 | |
Free Cash Flow |
(25.45) | (19.58) | (18.01) | (18.32) | |
Working Capital |
259.57 | 233.75 | 219.85 | 146.42 | |
Capital Expenditures |
(0.02) | (0.01) | 0.01 | (0.20) | |
Net Current Asset Value |
255.68 | 229.30 | 216.05 | 142.03 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.03 | (0.02) | 0.66 | |
Net Profit Margin |
(3,216.47%) | (13,805.02%) | (6,013.55%) | (6,936.86%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
2.43 | 5.29 | 4.42 | 3.59 | |
Average Assets |
268.45 | 269.24 | 210.76 | 177.43 | |
Average Common Equity |
225.49 | 215.92 | 160.01 | 136.61 |
Columns are period end dates